Law360, New York (November 03, 2009, 7:21 PM ET) -- A federal judge has purged state antitrust and consumer protection claims from a putative class action brought by employee benefit plans accusing GlaxoSmithKline PLC of filing baseless patent suits to delay generic versions of antidepressant Wellbutrin SR.
Judge Lawrence Stengel of the U.S. District Court for the Eastern District of Pennsylvania on Monday granted the drugmaker's motion to dismiss antitrust and consumer protection claims brought under a slew of state laws.
The judge granted the motion to dismiss those state law claims because the plaintiffs —...
Judge Pares Down Indirect Buyers' Wellbutrin Action
To view the full article, take a free trial now.
